The April issue of the TS Digest is out today! This includes: 🪐 An interview with a DNA-sequencing NASA astronaut 🪐 A cell atlas of the whole mouse brain 🪐 A big lesson on lab safety Read it today: https://ow.ly/4u5V50R5YLn
About us
The Scientist, the magazine of the life sciences, and the 2008 and 2009 ASBPE Magazine of the Year, has informed global life science professionals for over 25 years. We provide our print and online magazine readers with coverage of the latest developments in the life sciences including trends in research, new technology, news, business and careers. We reach the leading researchers and executive management in academia and industry who are interested in maintaining a broad view of the life sciences by reading insightful content that is current, concise and entertaining. For more information about The Scientist, visit http://www.the-scientist.com.
- Website
-
http://www.the-scientist.com
External link for The Scientist
- Industry
- Book and Periodical Publishing
- Company size
- 51-200 employees
- Headquarters
- Midland, ON
- Type
- Privately Held
- Founded
- 1986
- Specialties
- Life sciences, new media, magazine publishing, online, journalism, advertising, biotechnology, editorial, custom publishing, genomics, cancer research, laboratory research, science, libraries, and science research
Locations
-
Primary
PO Box 216
478 Bay Street
Midland, ON L4R 1K9, CA
-
1508 – 415 Madison Avenue
New York, NY 10017, US
Employees at The Scientist
Updates
-
Unlike with standard vaccines, it’s not possible to immunize against cancer before it develops. However, after decades of research, cancer vaccines may soon be part of effective treatment plans for patients. https://ow.ly/vSoh50Rk9MS
-
Originally derived from camelid heavy chain antibodies, single domain or VHH antibodies can bind epitopes that are inaccessible to conventional monoclonal antibodies due to their small size. Because of their many advantages, researchers investigate the therapeutic potential of single domain antibodies. Click the link below to learn more about generating single domain antibody-based therapeutics for autoimmune disorders, infectious diseases, and cancer in this poster sponsored by Abcore | Fortis Life Sciences. #AD https://ow.ly/OgHr50RaONt
Single Domain Antibodies: Small but Mighty Therapeutics
the-scientist.com
-
Going viral: bats harbor viruses that are deadly to humans and other mammals, but studying their immune systems may give scientists clues about how to mimic this viral resilience in humans. https://ow.ly/z6EC50Rk9bp
-
Join Shreya Udani as she discusses the novel sequencing technique, secretion-encoded single-cell sequencing (SEC-seq), in our upcoming Journal Club event. 📅 April 29 @ 2:30PM ET Future sessions: 📅 May 6 @ 2:30PM ET - Harrison Ramsay 📅 May 13 @ 2:30PM ET - Lilach Soreq Register today: https://ow.ly/sqpR50R2I3W
-
This week's newsletter covers everything from new interventions for Timothy syndrome from Sergiu P. Pașca to decomposing corpses to the first look at a virus's structure! You don't want to miss this one! Make sure you hit 'Subscribe' to get all the latest updates! #TimothySyndrome #Telomeres #LungCancer #BreastCancer #Bacteriophage #ForensicScience #Oxytocin #HumanAnatomy
Stop the Variant, Save the Channel and more!
The Scientist on LinkedIn
-
Using PET to analyze cancerous brain tissue is complicated by heterogeneity in the tumor microenvironment (TME). Many potential radiotracer targets are shared between tumor cells, TME cells, and resident cells of the brain, limiting PET signal interpretation. In a new translational medicine approach, glioblastoma PET scans are integrated with whole-brain 3D-histology at cellular resolution, and with single cells analysis post tumor dissociation and immunomagnetic cell sorting. This triangulation uncovers the cellular sources of PET signals and can be applied to identify novel radiotracer targets specific to immune cells of the glioblastoma TME. Register now #AD: https://ow.ly/sp2850Rjnnj
-
In this symposium, Jennifer Munson from Virginia Tech, Adrienne Boire from Memorial Sloan Kettering Cancer Center, Robert Insall from UCL, and Jean-François Côté from Institut de recherches cliniques de Montréal (IRCM) will discuss cellular mechanisms of metastasis, including tumor microenvironments, cell migration, anti-tumor immunity, and cytoskeletal dynamics. Join us: https://ow.ly/s58m50Rouvg
New Research Avenues Provide Hope for Metastatic Disease
the-scientist.com
-
A point mutation in a calcium channel exon prevents its proper function causing Timothy syndrome, a neurological disorder. In a new study recently published in Nature, Sergiu P. Pașca and his team at Stanford University used antisense oligonucleotides to return proper function to the cell. “Within a few days, you almost have only RNA that does not carry that mutation,” Pasca said. “That has immediate consequences on the physiology of the cells.” https://ow.ly/ttzO50RpiJp
Stop the Variant, Save the Channel
the-scientist.com
-
“Should we build a startup?” may be the academic equivalent to “Should we start a band?” But what does this look like for a university scientist? Hashim Al-Hashimi, a biophysicist at Columbia University and cofounder of Base4, shared his experience. Find out in this Beyond the Bench story: https://ow.ly/2GTJ50R8zyP